Viking Therapeutics
Focus: Viking Therapeutics is a San Diego-based biotech focused on therapeutics for metabolic and endocrine disorders, currently in clinical-stage development with a lean operational footprint.
Profile data last refreshed 4h ago · AI intelligence enriched 2w ago
Open Jobs
9+3 this month
Stable — net +3 jobs in 30d
4 added, 1 removed. Backfill posture.
Should You Work at Viking Therapeutics?
AI assessmentViking is an early-stage clinical biotech with compelling science in obesity/metabolic disease but high execution risk and limited near-term career stability.
Why Work Here
- Lead development of VK2735 in Phase 3 for weight loss, a high-demand therapeutic area with significant market potential
- Broad pipeline spanning metabolic diseases (NASH, hyperlipidemia), bone health (hip fractures), and rare genetic disorders (X-ALD)
Data completeness
2/9 — Limited
Company HealthStrong
Pipeline
Mid-stage
2 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Clinical Trials (1)
NCT04973657A Study to Assess the Pharmacodynamics of VK0214 in Male Subjects With AMN
Phase 1Help build intelligence for Viking Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.